Hatteras Discovery

Hatteras Discovery is a venture capital firm based in Durham, North Carolina, focusing on early and seed stage investments in the life sciences and healthcare sectors. Established in August 2011 as a subsidiary of Hatteras Venture Partners, it primarily targets therapeutic areas such as ophthalmology, cardiovascular, pulmonary, anti-infectives, oncology, immunology, and orphan diseases. The firm aims to invest between $0.25 million and $1 million in portfolio companies located in North Carolina, emphasizing its commitment to supporting regional innovation in healthcare. Hatteras Discovery leverages the expertise and resources of its parent company, which has a broader focus on biopharmaceuticals, medical devices, and healthcare technologies, thereby enhancing its ability to foster the growth of emerging companies in the healthcare landscape.